Evidence for the in vivo role of class II transactivator in basal and IFN-γ induced class II expression in mouse tissue

Transplantation

Volumn 62, Issue 12, 1996, Pages 1901-1907

  Ramassar, Vido ^a   Goes, Nelson ^a   Hobart, Michael ^a   Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CONFERENCE PAPER; GENE EXPRESSION REGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; ANTIGEN PRESENTATION; BINDING, COMPETITIVE; CYCLOHEXIMIDE; GENE AMPLIFICATION; GENE EXPRESSION; GENES, MHC CLASS II; INTERFERON TYPE II; KIDNEY; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, NUDE; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; TIME FACTORS; TISSUE DISTRIBUTION; TRANS-ACTIVATORS;

EID: 0030443838     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612270-00038     Document Type: Conference Paper

References (49)

1. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287.
2. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992; 10: 13.
3. Benoist C, Mathis D. Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 1990; 8: 681.
4. Barr CL, Saunders GF. Interferon γ inducible regulation of the human invariant chain gene. J Biol Chem 1991; 266: 3475.
5. Morris P, Shaman J, Attaya M, et al. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 1994; 368: 551.
6. Fling SP, Arp B, Pious D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 1994; 368: 554.
7. Ting JPY, Baldwin AS, Jr. Regulation of MHC gene expression. Curr Opin Immunol 1993; 5: 8.
8. Egan RM, Brockman JA, Omer KW, Woodward JG. Transcription of the murine class II Eb gene is regulated primarily at the level of transcriptional initiation. Cell Immunol 1994; 156: 537.
9. a complex expression causes a corresponding defect in antigen presentation. J Exp Med 1982; 155: 508.
10. a complex. J Exp Med 1982; 155: 490.
11. Matis LA, Glimcher LH, Paul WE, Schwartz RH. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and la molecules. Proc Natl Acad Sci USA 1983; 80: 6019.
12. Finn PW, Kara CJ, Douhan J III, Van TT, Folsom V, Glimcher LH. Interferon γ regulates binding of two nuclear protein complexes in a macrophage cell line. Proc Natl Acad Sci USA 1990; 87: 914.
13. Amaldi I, Reith W, Berte C, Mach B. Induction of HLA class II genes by IFN-γ is transcriptional and requires a trans-acting protein. J Immunol 1989; 142: 999.
14. Silacci P, Mottet A, Steimle V, Reith W, Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med 1994; 180: 1329.
15. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 1994; 265: 106.
16. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75: 135.
17. Chang CH, Fontes JD, Peterlin M, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994; 180: 1367.
18. Chin KC, Mao C, Skinner C, et al. Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1994; 1: 687.
19. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993; 259: 1739.
20. Goes N, Sims T, Urmson J, Vincent D, Ramassar V, Halloran PF. Disturbed MHC regulation in the interferon-γ knockout mouse. J Immunol 1995; 155: 4559.
21. Halloran PF, Autenried P, Ramassar V, Urmson J, Cockfield S. Local T cell responses induce widespread MHC expression: evidence that IFN-γ induces its own expression in remote sites. J Immunol 1992; 148: 3837.
22. Jephthah-Ochola J, Urmson J, Farkas S, Halloran PF. Regulation of MHC in vivo: bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell independent, cyclosporine sensitive mechanism. J Immunol 1988; 141: 792.
23. Spitalny GL, Havell EA. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 1984; 159: 1560.
24. Salacinski PRP, McLean C, Sykes JEC, Clements-Jones W, Lowry PJ. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3,6-diphenyl glycoluril (Iodogen). Anal Biochem 1981; 117: 136.
25. Cockfield SM, Ramassar V, Urmson J, Halloran PF. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-γ. J Immunol 1989; 142: 1120.
26. Halloran PF, Urmson J, Ramassar V, Laskin C, Autenried P. Increased class I and class II MHC products and mRNA in kidneys of MRL-Ipr/Ipr mice during autoimmune nephritis and inhibition by cyclosporine. J Immunol 1988; 141: 2303.
27. Chirgwin JM, Pryzybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294.
28. Chang C-H, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 1995; 181: 765.
29. Cockfield SM, Ramassar V, Noujaim J, van der Meide PH, Halloran PF. Regulation of IFN-γ expression in vivo: IFN-γ up-regulates expression of its mRNA in normal and lipopolysaccharide-stimulated mice. J Immunol 1993; 150: 717.
30. Halloran PF, Urmson J, Farkas S, Phillips RA, Fulop G, Cockfield S, Autenried P. Effects of cyclosporine on systemic MHC expression: evidence that non T cells produce gamma interferon in vivo and are inhibitable by cyclosporine A. Transplantation 1988; 46: 68S.
31. Cockfield SM, Ramassar V, Halloran PF. Regulation of IFN-γ and tumor necrosis factor-α expression in vivo. J Immunol 1993; 150: 342.
32. Lu L, Woo J, Rao AS, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179: 1823.
33. Zhou H, Glimcher LH. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 1995; 2: 545.
34. Mach B. MHC class II regulation - lessons from a disease. N Engl J Med 1995; 332: 120.
35. Darnell JE, Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415.
36. Sadowski HB, Shuai K, Darnell JE Jr, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 1993; 261: 1739.
37. Shuai K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ, Darnell JE. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 1993; 366: 580.
38. Shuai K, Stark GR, Kerr IM, Darnell JE Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 1993; 261: 1744.
39. Decker T, Lew DJ, Mirkovitch J, Darnell JE, Jr. Cytoplasmic activation of GAF, an IFN-γ-regulated DNA-binding factor. EMBO J 1991; 10: 927.
40. Müller M, Briscoe J, Laxton C, et al. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 1993; 366: 129.
41. Watling D, Guschin D, Müller M, et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature 1993; 366: 166.
42. Briken V, Ruffner H, Schultz U, et al. Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol Cell Biol 1995; 15: 975.
43. Lew DJ, Decker T, Strehlow I, Darnell JE. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by α and γ interferons. Mol Cell Biol 1991; 11: 182.
44. Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 1995; 9: 1021.
45. Mach B, Steimle V, Reith W. MHC class II-deficient combined immunodeficiency: a disease of gene regulation. Immunol Rev 1994; 138: 207.
46. Ting JPY, Painter A, Zeleznik-Le NJ, MacDonald G, Moore TM, Brown A, Schwartz BD. YB-1 DNA-binding protein represses interferon γ activation of class II major histocompatibility complex genes. J Exp Med 1994; 179: 1605.
47. Song Z, Krishna S, Thanos D, Strominger JL, Ono SJ. A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor. J Exp Med 1994; 180: 1763.
48. Iwata M, Kiritoshi A, Roat MI, Yagihashi A, Thoft RA. Regulation of HLA class II antigen expression on cultured corneal epithelium by interferon-gamma. Invest Ophthalmol Vis Sci 1992; 33: 2714.
49. Helbig H, Kittredge KL, Palestine AG, Coca-Prados M, Nussenblatt RB. Gamma-interferon induces differential expression of HLA-DR, -DP and -DQ in human ciliary epithelial cells. Graefes Arch Clin Exp Ophthalmol 1991; 229: 191.